Skip to content
NEPHNephros Inc

Earnings

When Nephros Inc reports, what it reported each quarter, and how the stock took the results.

66 quarters. Jun 30, 2010 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Feb 8, after the close

Mon, Feb 8, 2027in 93 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 26 – Mar 26

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$4.73M
Revenue, change from a year earlier: Q3 2026 +18.0%, Q2 2026 +36.2%, Q1 2026 +6.9%, Q4 2025 +22.2%
Net income
$62.00K
Net income, change from a year earlier: Q3 2026 +51.9%, Q2 2026 +405.1%, Q1 2026 −74.9%, Q4 2025 −82.2%
EPS
—
EPS, change from a year earlier: Q3 2026 +66.7%, Q2 2026 +450.0%, Q1 2026 −80.0%, Q3 2025 +50.0%

Quarter by quarter

Q3 2026$5.62M+18.0% vs Q3 2025

Latest results

  1. Q3 2026Nov 5, 2026, after the closeThe release
    Revenue
    $5.62M
    +18.0%
    Net income
    $512.00K
    +51.9%
    EPS
    $0.05
    +66.7%
    Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2026.
  2. Q2 2026Aug 6, 2026, after the closeThe release+21.5%by the close of Aug 7
    Revenue
    $6.02M
    +36.2%
    Net income
    $1.20M
    +405.1%
    EPS
    $0.11
    +450.0%
  3. Q1 2026May 7, 2026, after the closeThe release+11.0%by the close of May 8
    Revenue
    $5.21M
    +6.9%
    Net income
    $140.00K
    −74.9%
    EPS
    $0.01
    −80.0%
  4. Q4 2025Mar 12, 2026, after the close8.4%by the close of Mar 13
    Revenue
    $4.73M
    +22.2%
    Net income
    $62.00K
    −82.2%
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 5, 2026 · after-hoursNov 5, 202636 d10-Q$5.62M+18.0%$0.05—
Q2 2026Jun 30, 2026Aug 6, 2026 · after-hoursAug 10, 202641 d10-Q$6.02M+36.2%$0.11+21.5%
Q1 2026Mar 31, 2026May 7, 2026 · after-hoursMay 7, 202637 d10-Q$5.21M+6.9%$0.01+11.0%
FY 2025
Q4 2025derivedDec 31, 2025—Mar 12, 202671 d10-K$4.73M+22.2%—8.4%
Q3 2025Sep 30, 2025—Nov 6, 202537 d10-Q$4.76M+35.4%$0.0319.2%
Q2 2025Jun 30, 2025—Aug 7, 202538 d10-Q$4.42M+35.9%$0.02+33.1%
Q1 2025Mar 31, 2025May 8, 2025 · after-hoursMay 15, 202545 d10-Q$4.88M+38.5%$0.05—
FY 2024
Q4 2024derivedDec 31, 2024Mar 6, 2025 · after-hoursMar 24, 202583 d10-K$3.87M+18.9%—+14.6%
Q3 2024Sep 30, 2024Nov 13, 2024 · after-hoursNov 14, 202445 d10-Q$3.52M−6.0%$0.023.0%
Q2 2024Jun 30, 2024—Aug 8, 202439 d10-Q$3.25M−8.3%-$0.038.5%
Q1 2024Mar 31, 2024May 9, 2024 · after-hoursMay 9, 202439 d10-Q$3.52M−4.7%-$0.024.5%
Earlier years, FY 2010 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026050218
10-QAug 10, 2026036851
10-QMay 7, 2026021701
10-KMar 12, 2026009848
10-QNov 6, 2025021061
10-QAug 7, 2025022596
10-QMay 15, 2025010836
10-KMar 24, 2025000234
10-QNov 14, 2024045793
10-QAug 8, 2024030745

Provenance

ProvenanceData status and checks

Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR